MedTrace Logo

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia

NCT00111371 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-12-05

No results posted yet for this study

Summary

This study aims to determine whether levodopa, in combination with a high frequency training of (grammatical) rules, is effective in boosting learning success in healthy subjects and whether this kind of training in combination with levodopa improves reading and spelling abilities of patients with dyslexia.

Conditions

  • Dyslexia

Interventions

DRUG

Levodopa

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Stefan Knecht, Prof. Dr. · Dept. of Neurology, Universityclinic of Muenster

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Completion
2015-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00111371 on ClinicalTrials.gov